Anti-S26A9/ SLC26A9 monoclonal antibody

Anti-S26A9/ SLC26A9 antibody for FACS & in-vivo assay

Target products collectionGo to SLC26A9/SLC26A9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1580-Ab-1/ GM-Tg-hg-MP1580-Ab-2Anti-Human SLC26A9 monoclonal antibodyHuman
GM-Tg-rg-MP1580-Ab-1/ GM-Tg-rg-MP1580-Ab-2Anti-Rat SLC26A9 monoclonal antibodyRat
GM-Tg-mg-MP1580-Ab-1/ GM-Tg-mg-MP1580-Ab-2Anti-Mouse SLC26A9 monoclonal antibodyMouse
GM-Tg-cynog-MP1580-Ab-1/ GM-Tg-cynog-MP1580-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC26A9 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1580-Ab-1/ GM-Tg-felg-MP1580-Ab-2Anti-Feline SLC26A9 monoclonal antibodyFeline
GM-Tg-cang-MP1580-Ab-1/ GM-Tg-cang-MP1580-Ab-2Anti-Canine SLC26A9 monoclonal antibodyCanine
GM-Tg-bovg-MP1580-Ab-1/ GM-Tg-bovg-MP1580-Ab-2Anti-Bovine SLC26A9 monoclonal antibodyBovine
GM-Tg-equg-MP1580-Ab-1/ GM-Tg-equg-MP1580-Ab-2Anti-Equine SLC26A9 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1580-Ab-1/ GM-Tg-hg-MP1580-Ab-2; GM-Tg-rg-MP1580-Ab-1/ GM-Tg-rg-MP1580-Ab-2;
GM-Tg-mg-MP1580-Ab-1/ GM-Tg-mg-MP1580-Ab-2; GM-Tg-cynog-MP1580-Ab-1/ GM-Tg-cynog-MP1580-Ab-2;
GM-Tg-felg-MP1580-Ab-1/ GM-Tg-felg-MP1580-Ab-2; GM-Tg-cang-MP1580-Ab-1/ GM-Tg-cang-MP1580-Ab-2;
GM-Tg-bovg-MP1580-Ab-1/ GM-Tg-bovg-MP1580-Ab-2; GM-Tg-equg-MP1580-Ab-1/ GM-Tg-equg-MP1580-Ab-2
Products NameAnti-SLC26A9 monoclonal antibody
Formatmab
Target NameSLC26A9
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLC26A9 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species S26A9/ SLC26A9 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLV000699human SLC26A9 Lentivirus plasmid
    ORF Viral VectorpGMLV000044human SLC26A9 Lentivirus plasmid
    ORF Viral VectorvGMLV000699human SLC26A9 Lentivirus particle
    ORF Viral VectorvGMLV000044human SLC26A9 Lentivirus particle


    Target information

    Target IDGM-MP1580
    Target NameSLC26A9
    Gene ID115019,320718,304784,696461,478948,101087807,508958,100050693
    Gene Symbol and SynonymsE030002L01Rik,SLC26A9
    Uniprot AccessionQ7LBE3
    Uniprot Entry NameS26A9_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000174502
    Target ClassificationN/A

    The target: SLC26A9, gene name: SLC26A9, also named as . This gene is one member of a family of sulfate/anion transporter genes. Family members are well conserved in their genomic (number and size of exons) and protein (aa length among species) structures yet have markedly different tissue expression patterns. The product of this gene is a highly selective chloride ion channel regulated by WNK kinases. Alternative splicing results in multiple transcript variants encoding differing isoforms.[provided by RefSeq, Dec 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.